Clinical Trial Update: SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (SAVE-Care) is evaluating sodium-glucose cotransporter-2 inhibitors as a novel approach for gout care, and the study is currently not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout
• Hyperuricemia

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Gout and Hyperuricemia | Phase 4 | Status: NOT_YET_RECRUITING